Cytokine production of lung cancer cell lines:: Correlation between their production and the inflammatory/immunological responses both in vivo and in vitro

被引:71
作者
Fukuyama, Takashi [1 ]
Ichiki, Yoshinobu [1 ]
Yamada, Sousuke [1 ]
Shigematsu, Yoshiki [1 ]
Baba, Tetsuro [1 ]
Nagata, Yoshika [1 ]
Mizukami, Makiko [1 ]
Sugaya, Masakazu [1 ]
Takenoyama, Mitsuhiro [1 ]
Hanagiri, Takeshi [1 ]
Sugio, Kenji [1 ]
Yasumoto, Kosei [1 ]
机构
[1] Univ Occupat & Environm Hlth, Sch Med, Dept Surg 2, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan
关键词
D O I
10.1111/j.1349-7006.2007.00507.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cytokines produced by tumor cells may have various effects on antitumor immune responses and tumor growth. In the present study, the cytokine production of 31 lung cancer cell lines was evaluated, while any correlation with the histological type, the induction of tumor-specific cytotoxic T lymphocytes (CTL) in vitro, and angiogenesis and the infiltration of inflammatory cells in tumor tissues were also examined. Production of interleukin (IL)-1 alpha, IL-1 beta, IL-4, IL-6, IL-8, IL-10, tumor necrosis factor (TNF)-alpha, granulocyte macrophage colony stimulating factor (GM-CSF), granulocyte colony stimulating factor, transforming growth factor (TGF)-beta and vascular endothelial growth factor (VEGF) in the culture supernatant was measured using enzyme-linked immunosorbent assay. Each cytokine was produced in a substantial number of the tumor cell lines. In particular, IL-6, IL-8, TGF-beta and VEGF were produced in 18 (55%), 29 (94%), 31 (100%) and 28 (90%) of 31 cell lines, respectively. However, neither IL-4 nor TNF-alpha was produced at all by any tumor cell line. TGF-beta production was significantly higher in adenocarcinoma than in squamous cell carcinoma (P = 0.03). Immunohistochemical staining revealed the magnitude of macrophage infiltration, and angiogenesis in surgically resected tumor tissue specimens correlated well with GM-CSF and IL-8 production from the corresponding cell lines. Among six lung cancer cell lines, CTL were induced in the three lung cancer cell lines that produced a lower amount of TGF-beta (< 100 pg/mL). These findings suggested that TGF-beta produced by tumor cells could inhibit the induction of CTL in vitro. The present results suggest that the production of various cytokines from tumor cells might exert various paracrine effects both in vivo and in vitro.
引用
收藏
页码:1048 / 1054
页数:7
相关论文
共 40 条
[1]  
ALLEVA DG, 1994, J IMMUNOL, V153, P1674
[2]   Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice [J].
Arenberg, DA ;
Kunkel, SL ;
Polverini, PJ ;
Glass, M ;
Burdick, MD ;
Strieter, RM .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (12) :2792-2802
[3]  
BELLONE G, 1995, J IMMUNOL, V155, P1066
[4]   Tumour necrosis factor-α and transforming growth factor-β are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization [J].
Boldrini, L. ;
Calcinai, A. ;
Samaritani, E. ;
Pistolesi, F. ;
Mussi, A. ;
Lucchi, M. ;
Angeletti, C. A. ;
Basolo, F. ;
Fontanini, G. .
BRITISH JOURNAL OF CANCER, 2000, 83 (04) :480-486
[5]   Modulation by colony stimulating factors of human epithelial colon cancer cell apoptosis [J].
Calatayud, S ;
Warner, TD ;
Breese, EJ ;
Mitchell, JA .
CYTOKINE, 2002, 20 (04) :163-167
[6]   The biology of vascular endothelial growth factor [J].
Ferrara, N ;
DavisSmyth, T .
ENDOCRINE REVIEWS, 1997, 18 (01) :4-25
[7]   VEGF, a prosurvival factor, acts in concert with TGF-β1 to induce endothelial cell apoptosis [J].
Ferrari, Giovanni ;
Pintucci, Giuseppe ;
Seghezzi, Graziano ;
Hyman, Kevin ;
Galloway, Aubrey C. ;
Mignatti, Paolo .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (46) :17260-17265
[8]   Histological typing of lung and pleural tumours: third edition [J].
Gibbs, AR ;
Thunnissen, FBJM .
JOURNAL OF CLINICAL PATHOLOGY, 2001, 54 (07) :498-499
[9]   Regulatory T cells and inflammatory bowel disease [J].
Groux, H ;
Powrie, F .
IMMUNOLOGY TODAY, 1999, 20 (10) :442-446
[10]  
Hasegawa Y, 2001, CANCER-AM CANCER SOC, V91, P964, DOI 10.1002/1097-0142(20010301)91:5<964::AID-CNCR1086>3.0.CO